Effect of red yeast rice combined with antioxidants on lipid pattern, hs-CRP level, and endothelial function in moderately hypercholesterolemic subjects

Therapeutics and Clinical Risk Management

Volumn 12, Issue , 2016, Pages 281-286

  Cicero, Arrigo F G ^a   Morbini, Martino ^a   Parini, Angelo ^a   Urso, Riccardo ^a   Rosticci, Martina ^a   Grandi, Elisa ^a   Borghi, Claudio ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Clinical trial; High sensitivity C reactive protein; LDL cholesterol; Metalloproteinases; Monacolins; Nutraceutical

Indexed keywords

ANTIOXIDANT; ASTAXANTHIN; C REACTIVE PROTEIN; GREEN TEA EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONACOLIN; PLACEBO; QUERCETIN; RESVERATROL; TRIACYLGLYCEROL; UBIDECARENONE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG SAFETY; ENDOTHELIUM; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LIPID ANALYSIS; MALE; MYALGIA; PULSE VOLUME DISPLACEMENT; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VASCULAR REMODELING;

EID: 84959354505     PISSN: 11766336     EISSN: 1178203X     Source Type: Journal    
DOI: 10.2147/TCRM.S91817     Document Type: Article

References (39)

1. Cicero AF, Tartagni E, Ertek S. Nutraceuticals for metabolic syndrome management: from laboratory to benchside. Curr Vasc Pharmacol. 2014;12(4):565-571.
2. Cicero AF, Ferroni A, Ertek S. Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects. Expert Opin Drug Saf. 2012;11(5):753-766.
3. Derosa G, Cicero AF, Fogari E, D’Angelo A, Bonaventura A, Maffioli P. Effects of n-3 PUFAs on insulin resistance after an oral fat load. Eur J Lipid Sci Technol. 2011;113(8):950-960.
4. Derosa G, Cicero AF, Fogari E, et al. Effects of n-3 PUFAs effects on post-prandial variation of metalloproteinases, inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load. J Clin Lipidol. 2012;6(6):553-564.
5. Derosa G, Maffioli P, Cicero AF. Berberine on metabolic and cardiovascular risk factors: an analysis from preclinical evidences to clinical trials. Expert Opin Biol Ther. 2012;12(8):1113-1124.
6. Heber D, Lembertas A, Lu QY, Bowerman S, Go VL. An analysis of nine proprietary Chinese red yeast rice dietary supplements: implications of variability in chemical profile and contents. J Altern Complement Med. 2001;7(2):133-139.
7. Ma J, Li Y, Ye Q, et al. Constituents of red yeast rice, a traditional Chinese food and medicine. J Agric Food Chem. 2000;48(11):5220-5225.
8. Goldstein MR. Effects of dietary phytosterols on cholesterol metabolism and atherosclerosis. Am J Med. 2000;109(1):72-73.
9. Zhu L, Yau LF, Lu JG, et al. Cytotoxic dehydromonacolins from red yeast rice. J Agric Food Chem. 2012;60(4):934-939.
10. Zhu L, Lu JG, Li T, et al. Immunosuppressive decalin derivatives from red yeast rice. J Nat Prod. 2012;75(4):567-571.
11. Hasani-Ranjbar S, Nayebi N, Moradi L, Mehri A, Larijani B, Abdollahi M. The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia: a systematic review. Curr Pharm Des. 2010;16(26): 2935-2947.
12. Wang J, Su M, Lu Z, et al. Clinical trial of extract of Monascus purpureus (red yeast) in the treatment of hyperlipidemia. Chin J Exp Ther Prep Chin Med. 1995;12:1-5.
13. Heber D, Yip I, Ashley JM, Elashoff DA, Elashoff RM, Go VL. Cholesterol-lowering effects of a proprietary Chinese red-yeast-rice dietary supplement. Am J Clin Nutr. 1999;69(2):231-236.
14. Bogsrud MP, Ose L, Langslet G, et al. HypoCol (red yeast rice) lowers plasma cholesterol - a randomized placebo controlled study. Scand Cardiovasc J. 2010;44(4):197-200.
15. Guardamagna O, Abello F, Baracco V, Stasiowska B, Martino F. The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols. Nutr Metab Cardiovasc Dis. 2011;21(6):424-429.
16. Becker DJ, Gordon J, Halbert SC, French B, Morris PB, Rader DJ. Red yeast rice versus placebo in dyslipidemic, statin-intolerant patients enrolled in a therapeutic lifestyle program: a randomized, controlled trial. Ann Intern Med. 2009;150(12):830-839.
17. Halbert SC, French B, Gordon RY, et al. Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance. Am J Cardiol. 2010;105(2): 198-204.
18. European Food Safety Authority. Scientific opinion on the substantiation of health claims related to monacolin K from red yeast rice and maintenance of normal blood LDL cholesterol concentrations (ID 1648, 1700) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J. 2011;9(7):2304-2319.
19. Cicero AF, Derosa G, Parini A, et al. Red yeast rice improves lipid pattern, hs-CRP and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects. Nutr Res. 2013;33(8): 622-628.
20. Cicero AF, D’Addato S, Reggi A, Reggiani GM, Borghi C; on behalf of the Brisighella Heart Study. Hepatic steatosis index and lipid accumulation product as middle-term predictors of incident metabolic syndrome in a large population sample: data from the Brisighella Heart Study. Intern Emerg Med. 2013;8(3):265-267.
21. Rifai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity c-reactive protein assay. Clin Chem. 1999;45(12): 2136-2141.
22. Day LM, Maki-Petaja KM, Wilkinson IB, McEniery CM. Assessment of brachial artery reactivity using the Endocheck: repeatability, reproducibility and preliminary comparison with ultrasound. Artery Res. 2013;7(34):119-120.
23. Lin CC, Li TC, Lai MM. Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia. Eur J Endocrinol. 2005;153(5):679-686.
24. Gerards MC, Terlou RJ, Yu H, Koks CH, Gerdes VE. Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis. Atherosclerosis. 2015;240(2):415-423.
25. Ridker PM. A test in context: high-sensitivity C-reactive protein. J Am Coll Cardiol. 2016;67(6):712-723.
26. Zwaka TP, Hornbach V, Torzewski J. C-reactive protein mediated lipoprotein uptake by macrophages. Circulation. 2001;103(9):1194-1197.
27. Liu L, Zhao SP, Cheng YC, Li YL. Xuezhikang decreases serum lipoprotein(a) and C-reactive protein concentrations in patients with coronary heart disease. Clin Chem. 2003;49(8):1347-1352.
28. Derosa G, Bonaventura A, Bianchi L, et al. A randomized, placebo-controlled study on the effects of a nutraceutical combination of red yeast rice, Silybum marianum and octacosanol on lipid profile, endothelial and inflammatory parameters. J Biol Regul Homeost Agents. 2014; 28(2):317-324.
29. van Sloten TT, Henry RM, Dekker JM, et al. Endothelial dysfunction plays a key role in increasing cardiovascular risk in type 2 diabetes: the Hoorn study. Hypertension. 2014;64(6):1299-1305.
30. Hirata Y, Sugiyama S, Yamamoto E, et al. Endothelial function and cardiovascular events in chronic kidney disease. Int J Cardiol. 2014;173(3): 481-486.
31. Deanfield J, Donald A, Ferri C, et al; Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23(1):7-17.
32. Felmeden DC, Lip GY. Endothelial function and its assessment. Expert Opin Investig Drugs. 2005;14(11):1319-1336.
33. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol. 2002;39(2):257-265.
34. Affuso F, Ruvolo A, Micillo F, Saccà L, Fazio S. Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study. Nutr Metab Cardiovasc Dis. 2010;20(9):656-661.
35. Affuso F, Mercurio V, Ruvolo A, et al. A nutraceutical combination improves insulin sensitivity in patients with metabolic syndrome. World J Cardiol. 2012;4(3):77-83.
36. Khan F, Ray S, Craigie AM, et al. Lowering of oxidative stress improves endothelial function in healthy subjects with habitually low intake of fruit and vegetables: a randomized controlled trial of antioxidant- and polyphenol-rich blackcurrant juice. Free Radic Biol Med. 2014;72:232-237.
37. Siasos G, Tousoulis D, Kokkou E, et al. Favorable effects of concord grape juice on endothelial function and arterial stiffness in healthy smokers. Am J Hypertens. 2014;27(1):38-45.
38. Plantinga Y, Ghiadoni L, Magagna A, et al. Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens. 2007;20(4):392-397.
39. Wray DW, Nishiyama SK, Harris RA, et al. Acute reversal of endothelial dysfunction in the elderly after antioxidant consumption. Hypertension. 2012;59(4):818-824.